Opioid-Free Pain Control Regiment Following Robotic Radical Prostatectomy

Opioid-Free Pain Control Regiment Following Robotic Radical Prostatectomy: A Randomized Controlled Trial

This study will address the gaps in research of non-opioid postoperative pain management for prostatectomies.

This study will conduct a randomized control double-blind clinical trial to evaluate an opioid versus a non-opioid pathway of gabapentin, ketorolac, and acetaminophen in treating postoperative pain following robot-assisted radical prostatectomy (RARP).

Inclusion Criteria:

• All men ages 40-75 undergoing bilateral robot assisted radical prostatectomy (RARP) with bilateral lymph node dissection with low-intermediate to high-risk localized prostate cancer

Exclusion Criteria:

• Allergies to any medication involved in the study
• T4 prostate cancer
• incarcerated persons
• chronic narcotic dependence
• any current prescription for narcotics
• any surgery in the past 6 months